These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2402741)

  • 1. Hereditary dysfunctional protein C molecules (type II): assay characterization and proposed classification.
    Marlar RA; Adcock DM; Madden RM
    Thromb Haemost; 1990 Jun; 63(3):375-9. PubMed ID: 2402741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary protein C deficiency: a review of the genetics, clinical presentation, diagnosis and treatment.
    Marlar RA; Mastovich S
    Blood Coagul Fibrinolysis; 1990 Aug; 1(3):319-30. PubMed ID: 2103316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of protein C deficiency in patients on oral anticoagulant treatment: comparison of three different functional protein C assays.
    Pabinger I; Kyrle PA; Speiser W; Stoffels U; Jung M; Lechner K
    Thromb Haemost; 1990 Jun; 63(3):407-12. PubMed ID: 2402742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The protein C omega-loop substitution Asn2Ile is associated with reduced protein C anticoagulant activity.
    Preston RJ; Morse C; Murden SL; Brady SK; O'Donnell JS; Mumford AD
    Br J Haematol; 2009 Mar; 144(6):946-53. PubMed ID: 19133979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A family with an abnormal protein C and a thrombotic tendency.
    Girolami A; Simioni P; Lazzaro AR; Girolami B; Prandoni P
    Haematologia (Budap); 1993; 25(1):25-33. PubMed ID: 8339996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hereditary deficiency of antithrombin III, protein C, protein S and factor XII in 121 patients with venous or arterial thrombosis].
    Miljić P; Rolović Z; Elezović I; Antunović P; Stanojević M; Colović M
    Srp Arh Celok Lek; 1999; 127(1-2):21-7. PubMed ID: 10377836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a new venom-based clotting assay of protein C.
    Cooper PC; Cooper SM; Goodfellow KJ; Hickey KP; Kitchen S; Makris M
    Int J Lab Hematol; 2008 Oct; 30(5):437-43. PubMed ID: 19046320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical activity and gene analysis of inherited protein C and antithrombin deficiency in two Chinese pedigrees.
    Zhou RF; Fu QH; Wang WB; Xie S; Hu YQ; Wang XF; Wang ZY; Wang HL
    Chin Med J (Engl); 2004 Jun; 117(6):813-7. PubMed ID: 15198878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysfunctional activated protein C (PC Cádiz) in a patient with thrombotic disease.
    Sala N; Borrell M; Bauer KA; Viganò-D'Angelo S; Fontcuberta J; Félez J; Rutllant ML
    Thromb Haemost; 1987 Apr; 57(2):183-6. PubMed ID: 3037717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of the human protein C activator, Protac, on the activated partial thromboplastin clotting times of plasmas, with special reference to the dog.
    Johnstone IB; Martin CA
    Can J Vet Res; 2000 Apr; 64(2):117-22. PubMed ID: 10805251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal propeptide processing resulting in the presence of two abnormal species of protein C in plasma: characterization of the dysfunctional protein C Padua3 (protein C(R-1L/propeptide)).
    Simioni P; Kalafatis M; Tormene D; Luni S; Zerbinati P; Barzon L; Palù G; Girolami A
    Thromb Haemost; 2001 Oct; 86(4):1017-22. PubMed ID: 11686318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein C and protein S deficiencies.
    Aiach M; Borgel D; Gaussem P; Emmerich J; Alhenc-Gelas M; Gandrille S
    Semin Hematol; 1997 Jul; 34(3):205-16. PubMed ID: 9241706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunctional protein C deficiency (type II). A report of 11 cases in 3 American families and review of the literature.
    Berdeaux DH; Abshire TC; Marlar RA
    Am J Clin Pathol; 1993 Jun; 99(6):677-86. PubMed ID: 8322701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional assays for protein C activity and protein C inhibitor activity in plasma.
    Geiger M; White TM; Griffin JH
    Thromb Haemost; 1989 Feb; 61(1):86-92. PubMed ID: 2546280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coumarin necrosis, neonatal purpura fulminans, and protein C deficiency.
    Gladson CL; Groncy P; Griffin JH
    Arch Dermatol; 1987 Dec; 123(12):1701a-1706a. PubMed ID: 2961308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Type I hereditary protein C deficiency due to C5498T mutation in protein C gene].
    Zhou RF; Wang HL; Fu QH; Wang WB; Wu WM; Ding QL; Xie S; Hu YQ; Wang XF; Wang ZY
    Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(19):1694-7. PubMed ID: 14642106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of a functional and immunologic assay for plasma protein C in the study of the heterogeneity of congenital protein C deficiency.
    Bertina RM; Broekmans AW; Krommenhoek-van Es C; van Wijngaarden A
    Thromb Haemost; 1984 Feb; 51(1):1-5. PubMed ID: 6547008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble endothelial protein C receptor (sEPCR) levels and venous thromboembolism in carriers of two dysfunctional protein C variants.
    Simioni P; Morboeuf O; Tognin G; Gavasso S; Tormene D; Woodhams B; Pagnan A
    Thromb Res; 2006; 117(5):523-8. PubMed ID: 15921724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein C and protein S assessment in hospital laboratories: which strategy and what role for DNA sequencing?
    Labrouche S; Reboul MP; Guérin V; Vergnes C; Freyburger G
    Blood Coagul Fibrinolysis; 2003 Sep; 14(6):531-8. PubMed ID: 12960605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked discrepancy between coagulometric protein C activity assays with the pro-thrombotic protein C Asn2Ile substitution.
    Cooper PC; Siddiq S; Morse C; Nightingale J; Mumford AD
    Int J Lab Hematol; 2011 Oct; 33(5):451-6. PubMed ID: 21418542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.